Back to Company Profile
Alpha

Alpha Profiles · Company Profile

Bicara Therapeutics Inc.

Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts.

https://registry.alpha.ac/companies/bicara-therapeutics-inc

Bicara Therapeutics Inc. logo
Entity
Public listing published
Primary listing
NASDAQ: BCAX
Verification
Partially verified
Last reviewed
2026-10-03T04:45:59.851839+00:00

Overview

Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

0 public records

Executive roster coverage is NOT_ASSERTED. An empty list is not evidence that this company has no executive team.

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 3, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

9 public records

Committees

1 public record

Membership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.

AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC

Chair
Scott Robertson
Members
Scott Robertson (Chair); Carolyn Ng; Michael Powell

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-10-03T04:45:59.851839+00:00

Generated 2026-10-03T06:30:04.336Z

Data as of 2026-10-03T04:45:59.851839+00:00

https://registry.alpha.ac/companies/bicara-therapeutics-inc